Lexicon Pharmaceuticals (LXRX) Short-term Investments: 2009-2011
Historic Short-term Investments for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2011 value amounting to $95.4 million.
- Lexicon Pharmaceuticals' Short-term Investments rose 63.76% to $186.1 million in Q3 2012 from the same period last year, while for Sep 2012 it was $186.1 million, marking a year-over-year increase of 63.76%. This contributed to the annual value of $95.4 million for FY2011, which is 41.81% down from last year.
- As of FY2011, Lexicon Pharmaceuticals' Short-term Investments stood at $95.4 million, which was down 41.81% from $163.9 million recorded in FY2010.
- Lexicon Pharmaceuticals' Short-term Investments' 5-year high stood at $163.9 million during FY2010, with a 5-year trough of $56.5 million in FY2009.
- Moreover, its 3-year median value for Short-term Investments was $95.4 million (2011), whereas its average is $105.3 million.
- Its Short-term Investments has fluctuated over the past 5 years, first skyrocketed by 189.88% in 2010, then crashed by 41.81% in 2011.
- Yearly analysis of 3 years shows Lexicon Pharmaceuticals' Short-term Investments stood at $56.5 million in 2009, then skyrocketed by 189.88% to $163.9 million in 2010, then crashed by 41.81% to $95.4 million in 2011.